Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
M Galli, D Luciani, G Bertolini… - Blood, The Journal of the …, 2003 - ashpublications.org
To formally establish the risk of lupus anticoagulants and anticardiolipin antibodies for
arterial and venous thrombosis, we ran a MEDLINE search of the literature from 1988 to …
arterial and venous thrombosis, we ran a MEDLINE search of the literature from 1988 to …
Silicon nanostructures for photonics and photovoltaics
Silicon has long been established as the material of choice for the microelectronics industry.
This is not yet true in photonics, where the limited degrees of freedom in material design …
This is not yet true in photonics, where the limited degrees of freedom in material design …
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
…, G Rizzardini, S Antinori, M Galli - Clinical and …, 2020 - europepmc.org
A severe outbreak of coronavirus disease 2019 (COVID-19) emerged in China in December
2019, and spread so rapidly that more than 200,000 cases have so far been reported …
2019, and spread so rapidly that more than 200,000 cases have so far been reported …
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
M Galli, T Barbui, P Comfurius, C Maassen… - The Lancet, 1990 - Elsevier
The binding of affinity-purified anticardiolipin antibodies (ACA) to liposomes that contained
cardiolipin or phosphatidylserine was investigated. ACA bound to these liposomes only in …
cardiolipin or phosphatidylserine was investigated. ACA bound to these liposomes only in …
Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study
…, G Rizzardini, S Antinori, M Galli - Clinical infectious …, 2020 - academic.oup.com
To the Editor—We read with interest the article by Wang et al [1] describing the clinical
features of 69 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
features of 69 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] Remdesivir for 5 or 10 days in patients with severe Covid-19
…, R Montejano, CD Spinner, M Galli… - … England Journal of …, 2020 - Mass Medical Soc
Background Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …
[PDF][PDF] Determination and inference of eukaryotic transcription factor sequence specificity
Transcription factor (TF) DNA sequence preferences direct their regulatory activity, but are
currently known for only∼ 1% of eukaryotic TFs. Broadly sampling DNA-binding domain …
currently known for only∼ 1% of eukaryotic TFs. Broadly sampling DNA-binding domain …
[HTML][HTML] Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
…, S Antinori, M Corbellino, M Galli… - The Lancet infectious …, 2020 - thelancet.com
Background COVID-19 is characterised by respiratory symptoms, which deteriorate into
respiratory failure in a substantial proportion of cases, requiring intensive care in up to a …
respiratory failure in a substantial proportion of cases, requiring intensive care in up to a …
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
Background It is unclear whether radial compared with femoral access improves outcomes
in unselected patients with acute coronary syndromes undergoing invasive management …
in unselected patients with acute coronary syndromes undergoing invasive management …
[HTML][HTML] Update of the guidelines for lupus anticoagulant detection
…, A Tripodi, G Reber, JH Rand, TL Ortel, M Galli… - Journal of Thrombosis …, 2009 - Elsevier
One of the conclusions of the subcommittee meeting on Lupus Anticoagulant/Phospholipid
dependent antibodies, held in Geneva on 2007, was the need to update the guidelines on …
dependent antibodies, held in Geneva on 2007, was the need to update the guidelines on …